A Pilot Study of Synbiotics in Adults With Depressive Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGenieBiome Limited
About this trial
This study aims to explore the efficacy and safety of a synbiotic formula (MQU10) in improving mood and well-being in adults with mild to moderate depressive symptoms.
Eligibility criteria
Qualifiers
Individuals aged 18 or above
Patient Health Questionnaire-9 (PHQ-9) score between 5 to 14
Literate and can complete the self-report questionnaires
Able to understand the consent and sign the informed consent form
Disqualifiers
Current diagnosis of substance abuse or dependence;
A current or past history of bipolar disorder, manic or hypomanic episodes, schizophrenia, personality disorder, posttraumatic stress disorder (PTSD), intellectual disability, neurodegenerative disorders (e. g, Parkinson's disease) or organic mental disorder
Requiring immediate psychiatric care (e. g, imminently suicidal subjects) or have attempted suicide in the past 3 months
Use of antipsychotics, antidepressants or sedatives, unless on a stable dose in the last 4 weeks
Trial design
Treatments tested in this trial
- MQU10
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov